Trial by Tech: The Evolution of the Digital Courtroom – Speaking of Litigation Video Podcast
Information Security and ISO 27001
No Password Required: LIVE From Sunshine Cyber Con
Calculating eDiscovery Costs: Tips from Brett Burney
No Password Required: President at Constellation Cyber, Former FBI Translator, and Finder of Non-Magical Mushrooms
Managing Large Scale Review Efficiency: Tips From a GC
DE Under 3: US DOL Inspector General’s Office Report Cites IT Modernization & Security Concerns
RegFi Episode 8: The Technological Path to Outcomes-Based Regulation with Matt Van Buskirk
Podcast: Discussing Information Blocking with Eddie Williams
The Data Center Cooling Conundrum With Leland Sparks - TAG Infrastructure Talks Podcast
[Podcast] TikTok off the Clock: Navigating the TikTok Ban on Devices for Government Contractors
Everything Dynamic Everywhere: Managing a More Collaborative Microsoft 365
Law Firm ILN-telligence Podcast | Episode 62: Pierre Hurt, Lutgen & Associes | Luxembourg
ATL1, Atlanta Infrastructure and More With Brandon Peccoralo of Databank - TAG Infrastructure Talks Podcast
Expanded Information Block Rules Go into Effect
5 Key Takeaways | Current Perspectives Around the Convergence of Life Sciences and IT
No Password Required: A Child of the 1980s With a Knack for Storytelling, Comedic Timing, and Building an Elite Cybersecurity Team
Changing Hands: Keys To Downstream M&A IT Integration
Mia Reini and Monica Lopez Reinmiller on a Risk-Based Approach to Managing Employee Hotlines
Jannica Houben and Katarzyna Golonka on Complex Investigations
House Passes Legislation to Prohibit Use of QALYs in All Federal Health Programs. The House passed H.R. 485, the Protecting Health Care for All Patients Act of 2023, a bill designed to prohibit the use of QALYs and similar...more
The digital health market is projected to reach $536.6 billion by 2025 and transform every aspect of healthcare. Which advances hold true potential and which are just hype? Find out at a new Manatt webinar. Digital...more
Innovation in the life sciences and health care industries is occurring at a dizzying pace. Five years ago, anti-PD-1 antibodies from Merck and BMS had yet to be approved, CAR-T therapies were still in small-scale clinical...more